PDB Short entry for 4ACC HEADER TRANSFERASE 14-DEC-11 4ACC TITLE GSK3B IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GSK-3 BETA, SERINE/THREONINE-PROTEIN KINASE GSK3B,; COMPND 5 EC: 2.7.11.1, 2.7.11.26; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PFASTBAC HTB KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,M.ORMO REVDAT 3 14-FEB-18 4ACC 1 JRNL REVDAT 2 21-NOV-12 4ACC 1 JRNL REVDAT 1 16-MAY-12 4ACC 0 JRNL AUTH S.BERG,M.BERGH,S.HELLBERG,K.HOGDIN,Y.LO-ALFREDSSON, JRNL AUTH 2 P.SODERMAN,S.VON BERG,T.WEIGELT,M.ORMO,Y.XUE,J.TUCKER, JRNL AUTH 3 J.NEELISSEN,E.JERNING,Y.NILSSON,R.BHAT JRNL TITL DISCOVERY OF NOVEL POTENT AND HIGHLY SELECTIVE GLYCOGEN JRNL TITL 2 SYNTHASE KINASE-3 BETA (GSK3 BETA ) INHIBITORS FOR JRNL TITL 3 ALZHEIMER'S DISEASE: DESIGN, SYNTHESIS, AND CHARACTERIZATION JRNL TITL 4 OF PYRAZINES. JRNL REF J. MED. CHEM. V. 55 9107 2012 JRNL REFN ISSN 1520-4804 JRNL PMID 22489897 JRNL DOI 10.1021/JM201724M REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.2 REMARK 3 NUMBER OF REFLECTIONS : 58051 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 2946 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.27 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.24 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2712 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2410 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2567 REMARK 3 BIN R VALUE (WORKING SET) : 0.2407 REMARK 3 BIN FREE R VALUE : 0.2462 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.35 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 145 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5610 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 512 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.74040 REMARK 3 B22 (A**2) : -14.29370 REMARK 3 B33 (A**2) : 17.03410 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.272 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.195 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.166 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.186 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.164 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5827 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7927 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1990 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 126 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 856 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5827 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 2 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 750 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6728 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.15 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.07 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 TYPES WITHOUT CCP4 ATOM TYPE IN LIBRARY=DMS. NUMBER OF ATOMS REMARK 3 WITH PROPER CCP4 ATOM TYPE=6120. NUMBER WITH APPROX DEFAULT CCP4 REMARK 3 ATOM TYPE=12. NUMBER TREATED BY BAD NON-BONDED CONTACTS=64. REMARK 4 REMARK 4 4ACC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-DEC-11. REMARK 100 THE DEPOSITION ID IS D_1290050706. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 173 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9393 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58113 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.210 REMARK 200 RESOLUTION RANGE LOW (A) : 59.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.5 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.54000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.76500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.90500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 88.76500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.54000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.90500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -44 REMARK 465 SER A -43 REMARK 465 TYR A -42 REMARK 465 TYR A -41 REMARK 465 HIS A -40 REMARK 465 HIS A -39 REMARK 465 HIS A -38 REMARK 465 HIS A -37 REMARK 465 HIS A -36 REMARK 465 HIS A -35 REMARK 465 ASP A -34 REMARK 465 TYR A -33 REMARK 465 ASP A -32 REMARK 465 ILE A -31 REMARK 465 PRO A -30 REMARK 465 THR A -29 REMARK 465 THR A -28 REMARK 465 GLU A -27 REMARK 465 ASN A -26 REMARK 465 LEU A -25 REMARK 465 TYR A -24 REMARK 465 PHE A -23 REMARK 465 GLN A -22 REMARK 465 GLY A -21 REMARK 465 ALA A -20 REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 ARG A 4 REMARK 465 PRO A 5 REMARK 465 ARG A 6 REMARK 465 THR A 7 REMARK 465 THR A 8 REMARK 465 SER A 9 REMARK 465 PHE A 10 REMARK 465 ALA A 11 REMARK 465 GLU A 12 REMARK 465 SER A 13 REMARK 465 CYS A 14 REMARK 465 LYS A 15 REMARK 465 PRO A 16 REMARK 465 VAL A 17 REMARK 465 GLN A 18 REMARK 465 GLN A 19 REMARK 465 PRO A 20 REMARK 465 SER A 21 REMARK 465 ALA A 22 REMARK 465 PHE A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 MET A 26 REMARK 465 LYS A 27 REMARK 465 VAL A 28 REMARK 465 SER A 29 REMARK 465 ARG A 30 REMARK 465 ASP A 31 REMARK 465 LYS A 32 REMARK 465 ASP A 33 REMARK 465 GLY A 34 REMARK 465 ALA A 386 REMARK 465 ALA A 387 REMARK 465 ALA A 388 REMARK 465 SER A 389 REMARK 465 THR A 390 REMARK 465 PRO A 391 REMARK 465 THR A 392 REMARK 465 ASN A 393 REMARK 465 ALA A 394 REMARK 465 THR A 395 REMARK 465 ALA A 396 REMARK 465 ALA A 397 REMARK 465 SER A 398 REMARK 465 ASP A 399 REMARK 465 ALA A 400 REMARK 465 ASN A 401 REMARK 465 THR A 402 REMARK 465 GLY A 403 REMARK 465 ASP A 404 REMARK 465 ARG A 405 REMARK 465 GLY A 406 REMARK 465 GLN A 407 REMARK 465 THR A 408 REMARK 465 ASN A 409 REMARK 465 ASN A 410 REMARK 465 ALA A 411 REMARK 465 ALA A 412 REMARK 465 SER A 413 REMARK 465 ALA A 414 REMARK 465 SER A 415 REMARK 465 ALA A 416 REMARK 465 SER A 417 REMARK 465 ASN A 418 REMARK 465 SER A 419 REMARK 465 THR A 420 REMARK 465 MET B -44 REMARK 465 SER B -43 REMARK 465 TYR B -42 REMARK 465 TYR B -41 REMARK 465 HIS B -40 REMARK 465 HIS B -39 REMARK 465 HIS B -38 REMARK 465 HIS B -37 REMARK 465 HIS B -36 REMARK 465 HIS B -35 REMARK 465 ASP B -34 REMARK 465 TYR B -33 REMARK 465 ASP B -32 REMARK 465 ILE B -31 REMARK 465 PRO B -30 REMARK 465 THR B -29 REMARK 465 THR B -28 REMARK 465 GLU B -27 REMARK 465 ASN B -26 REMARK 465 LEU B -25 REMARK 465 TYR B -24 REMARK 465 PHE B -23 REMARK 465 GLN B -22 REMARK 465 GLY B -21 REMARK 465 ALA B -20 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 ARG B 4 REMARK 465 PRO B 5 REMARK 465 ARG B 6 REMARK 465 THR B 7 REMARK 465 THR B 8 REMARK 465 SER B 9 REMARK 465 PHE B 10 REMARK 465 ALA B 11 REMARK 465 GLU B 12 REMARK 465 SER B 13 REMARK 465 CYS B 14 REMARK 465 LYS B 15 REMARK 465 PRO B 16 REMARK 465 VAL B 17 REMARK 465 GLN B 18 REMARK 465 GLN B 19 REMARK 465 PRO B 20 REMARK 465 SER B 21 REMARK 465 ALA B 22 REMARK 465 PHE B 23 REMARK 465 GLY B 24 REMARK 465 SER B 25 REMARK 465 MET B 26 REMARK 465 LYS B 27 REMARK 465 VAL B 28 REMARK 465 SER B 29 REMARK 465 ARG B 30 REMARK 465 ASP B 31 REMARK 465 LYS B 32 REMARK 465 ASP B 33 REMARK 465 GLY B 34 REMARK 465 ALA B 386 REMARK 465 ALA B 387 REMARK 465 ALA B 388 REMARK 465 SER B 389 REMARK 465 THR B 390 REMARK 465 PRO B 391 REMARK 465 THR B 392 REMARK 465 ASN B 393 REMARK 465 ALA B 394 REMARK 465 THR B 395 REMARK 465 ALA B 396 REMARK 465 ALA B 397 REMARK 465 SER B 398 REMARK 465 ASP B 399 REMARK 465 ALA B 400 REMARK 465 ASN B 401 REMARK 465 THR B 402 REMARK 465 GLY B 403 REMARK 465 ASP B 404 REMARK 465 ARG B 405 REMARK 465 GLY B 406 REMARK 465 GLN B 407 REMARK 465 THR B 408 REMARK 465 ASN B 409 REMARK 465 ASN B 410 REMARK 465 ALA B 411 REMARK 465 ALA B 412 REMARK 465 SER B 413 REMARK 465 ALA B 414 REMARK 465 SER B 415 REMARK 465 ALA B 416 REMARK 465 SER B 417 REMARK 465 ASN B 418 REMARK 465 SER B 419 REMARK 465 THR B 420 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 385 CA C O CB CG CD OE1 REMARK 470 GLN A 385 NE2 REMARK 470 GLN B 385 CA C O CB CG CD OE1 REMARK 470 GLN B 385 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 49 76.98 -65.59 REMARK 500 ASP A 77 -72.71 -55.60 REMARK 500 GLU A 121 12.69 -147.88 REMARK 500 LYS A 122 -125.57 -137.66 REMARK 500 LYS A 123 -80.79 -144.38 REMARK 500 ASP A 181 46.66 -143.24 REMARK 500 ASP A 200 88.25 61.59 REMARK 500 CYS A 218 138.09 77.60 REMARK 500 TYR A 221 -30.16 94.96 REMARK 500 PHE A 257 64.30 -119.55 REMARK 500 ASN A 287 30.86 -81.88 REMARK 500 GLN A 295 95.26 -68.97 REMARK 500 ASN A 370 74.96 -160.16 REMARK 500 ASP B 49 85.80 -68.89 REMARK 500 ASP B 181 46.87 -143.66 REMARK 500 ASP B 200 88.29 61.79 REMARK 500 CYS B 218 137.96 75.79 REMARK 500 TYR B 221 -30.62 93.46 REMARK 500 PHE B 257 64.86 -119.37 REMARK 500 GLN B 295 96.62 -69.46 REMARK 500 ASN B 370 74.76 -158.35 REMARK 500 ILE B 384 115.70 -15.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 1385 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 1386 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS B 1385 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7YG A 1387 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7YG B 1386 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GNG RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE 3BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE REMARK 900 RELATED ID: 1H8F RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA. REMARK 900 RELATED ID: 1I09 RELATED DB: PDB REMARK 900 STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B) REMARK 900 RELATED ID: 1J1B RELATED DB: PDB REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITHAMPPNP REMARK 900 RELATED ID: 1J1C RELATED DB: PDB REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITHADP REMARK 900 RELATED ID: 1O6K RELATED DB: PDB REMARK 900 STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 REMARK 900 PEPTIDE AND AMP-PNP REMARK 900 RELATED ID: 1O6L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF REMARK 900 CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE REMARK 900 RELATED ID: 1O9U RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE REMARK 900 RELATED ID: 1PYX RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH AMP-PNP REMARK 900 RELATED ID: 1Q3D RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH STAUROSPORINE REMARK 900 RELATED ID: 1Q3W RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE REMARK 900 RELATED ID: 1Q41 RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'-MONOXIME REMARK 900 RELATED ID: 1Q4L RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH INHIBITOR I-5 REMARK 900 RELATED ID: 1Q5K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 INCOMPLEXED WITH REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1R0E RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3- INDOLYL-4- REMARK 900 ARYLMALEIMIDE INHIBITOR REMARK 900 RELATED ID: 1UV5 RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6- BROMOINDIRUBIN-3'- REMARK 900 OXIME REMARK 900 RELATED ID: 2JDO RELATED DB: PDB REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE -5- REMARK 900 SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO) ETHYL)AMIDE REMARK 900 RELATED ID: 2JDR RELATED DB: PDB REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654 REMARK 900 RELATED ID: 2JLD RELATED DB: PDB REMARK 900 EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE REMARK 900 KINASE 3 REMARK 900 RELATED ID: 2UW9 RELATED DB: PDB REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4- CHLORO-PHENYL)-4- REMARK 900 (4-(1H-PYRAZOL-4-YL)-PHENYL)- PIPERIDINE REMARK 900 RELATED ID: 2X37 RELATED DB: PDB REMARK 900 STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2 ,3-D)PYRIMIDIN- REMARK 900 4-YL)PIPERIDIN-4-AMINE BOUND TO PKB REMARK 900 RELATED ID: 2X39 RELATED DB: PDB REMARK 900 STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H- PYRROLO(2,3-D) REMARK 900 PYRIMIDIN-4-YL)PIPERIDINE-4- CARBOXAMIDE BOUND TO PKB REMARK 900 RELATED ID: 2XH5 RELATED DB: PDB REMARK 900 STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2 ,3-D)PYRIMIDIN- REMARK 900 4-YL)PIPERIDIN-4-AMINE BOUND TO PKB REMARK 900 RELATED ID: 3ZRK RELATED DB: PDB REMARK 900 IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK -3BETA REMARK 900 INHIBITORS REMARK 900 RELATED ID: 3ZRL RELATED DB: PDB REMARK 900 IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK -3BETA REMARK 900 INHIBITORS REMARK 900 RELATED ID: 3ZRM RELATED DB: PDB REMARK 900 IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK -3BETA REMARK 900 INHIBITORS REMARK 900 RELATED ID: 4ACD RELATED DB: PDB REMARK 900 GSK3B IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 4ACG RELATED DB: PDB REMARK 900 GSK3B IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 4ACH RELATED DB: PDB REMARK 900 GSK3B IN COMPLEX WITH INHIBITOR DBREF 4ACC A 1 420 UNP P49841 GSK3B_HUMAN 1 420 DBREF 4ACC B 1 420 UNP P49841 GSK3B_HUMAN 1 420 SEQADV 4ACC MET A -44 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER A -43 UNP P49841 EXPRESSION TAG SEQADV 4ACC TYR A -42 UNP P49841 EXPRESSION TAG SEQADV 4ACC TYR A -41 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -40 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -39 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -38 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -37 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -36 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -35 UNP P49841 EXPRESSION TAG SEQADV 4ACC ASP A -34 UNP P49841 EXPRESSION TAG SEQADV 4ACC TYR A -33 UNP P49841 EXPRESSION TAG SEQADV 4ACC ASP A -32 UNP P49841 EXPRESSION TAG SEQADV 4ACC ILE A -31 UNP P49841 EXPRESSION TAG SEQADV 4ACC PRO A -30 UNP P49841 EXPRESSION TAG SEQADV 4ACC THR A -29 UNP P49841 EXPRESSION TAG SEQADV 4ACC THR A -28 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLU A -27 UNP P49841 EXPRESSION TAG SEQADV 4ACC ASN A -26 UNP P49841 EXPRESSION TAG SEQADV 4ACC LEU A -25 UNP P49841 EXPRESSION TAG SEQADV 4ACC TYR A -24 UNP P49841 EXPRESSION TAG SEQADV 4ACC PHE A -23 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLN A -22 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLY A -21 UNP P49841 EXPRESSION TAG SEQADV 4ACC ALA A -20 UNP P49841 EXPRESSION TAG SEQADV 4ACC MET A -19 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLY A -18 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER A -17 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER A -16 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -15 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -14 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -13 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -12 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -11 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A -10 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER A -9 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER A -8 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLY A -7 UNP P49841 EXPRESSION TAG SEQADV 4ACC LEU A -6 UNP P49841 EXPRESSION TAG SEQADV 4ACC VAL A -5 UNP P49841 EXPRESSION TAG SEQADV 4ACC PRO A -4 UNP P49841 EXPRESSION TAG SEQADV 4ACC ARG A -3 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLY A -2 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER A -1 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS A 0 UNP P49841 EXPRESSION TAG SEQADV 4ACC MET B -44 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER B -43 UNP P49841 EXPRESSION TAG SEQADV 4ACC TYR B -42 UNP P49841 EXPRESSION TAG SEQADV 4ACC TYR B -41 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -40 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -39 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -38 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -37 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -36 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -35 UNP P49841 EXPRESSION TAG SEQADV 4ACC ASP B -34 UNP P49841 EXPRESSION TAG SEQADV 4ACC TYR B -33 UNP P49841 EXPRESSION TAG SEQADV 4ACC ASP B -32 UNP P49841 EXPRESSION TAG SEQADV 4ACC ILE B -31 UNP P49841 EXPRESSION TAG SEQADV 4ACC PRO B -30 UNP P49841 EXPRESSION TAG SEQADV 4ACC THR B -29 UNP P49841 EXPRESSION TAG SEQADV 4ACC THR B -28 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLU B -27 UNP P49841 EXPRESSION TAG SEQADV 4ACC ASN B -26 UNP P49841 EXPRESSION TAG SEQADV 4ACC LEU B -25 UNP P49841 EXPRESSION TAG SEQADV 4ACC TYR B -24 UNP P49841 EXPRESSION TAG SEQADV 4ACC PHE B -23 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLN B -22 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLY B -21 UNP P49841 EXPRESSION TAG SEQADV 4ACC ALA B -20 UNP P49841 EXPRESSION TAG SEQADV 4ACC MET B -19 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLY B -18 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER B -17 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER B -16 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -15 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -14 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -13 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -12 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -11 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B -10 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER B -9 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER B -8 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLY B -7 UNP P49841 EXPRESSION TAG SEQADV 4ACC LEU B -6 UNP P49841 EXPRESSION TAG SEQADV 4ACC VAL B -5 UNP P49841 EXPRESSION TAG SEQADV 4ACC PRO B -4 UNP P49841 EXPRESSION TAG SEQADV 4ACC ARG B -3 UNP P49841 EXPRESSION TAG SEQADV 4ACC GLY B -2 UNP P49841 EXPRESSION TAG SEQADV 4ACC SER B -1 UNP P49841 EXPRESSION TAG SEQADV 4ACC HIS B 0 UNP P49841 EXPRESSION TAG SEQRES 1 A 465 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 A 465 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET SEQRES 3 A 465 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 4 A 465 VAL PRO ARG GLY SER HIS MET SER GLY ARG PRO ARG THR SEQRES 5 A 465 THR SER PHE ALA GLU SER CYS LYS PRO VAL GLN GLN PRO SEQRES 6 A 465 SER ALA PHE GLY SER MET LYS VAL SER ARG ASP LYS ASP SEQRES 7 A 465 GLY SER LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN SEQRES 8 A 465 GLY PRO ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR SEQRES 9 A 465 LYS VAL ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN SEQRES 10 A 465 ALA LYS LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS SEQRES 11 A 465 LYS VAL LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU SEQRES 12 A 465 GLN ILE MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG SEQRES 13 A 465 LEU ARG TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP SEQRES 14 A 465 GLU VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU SEQRES 15 A 465 THR VAL TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS SEQRES 16 A 465 GLN THR LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR SEQRES 17 A 465 GLN LEU PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY SEQRES 18 A 465 ILE CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU SEQRES 19 A 465 ASP PRO ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SEQRES 20 A 465 SER ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER SEQRES 21 A 465 TYR ILE CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE SEQRES 22 A 465 PHE GLY ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SEQRES 23 A 465 SER ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN SEQRES 24 A 465 PRO ILE PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL SEQRES 25 A 465 GLU ILE ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN SEQRES 26 A 465 ILE ARG GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE SEQRES 27 A 465 PRO GLN ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG SEQRES 28 A 465 PRO ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG SEQRES 29 A 465 LEU LEU GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU SEQRES 30 A 465 GLU ALA CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP SEQRES 31 A 465 PRO ASN VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA SEQRES 32 A 465 LEU PHE ASN PHE THR THR GLN GLU LEU SER SER ASN PRO SEQRES 33 A 465 PRO LEU ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE SEQRES 34 A 465 GLN ALA ALA ALA SER THR PRO THR ASN ALA THR ALA ALA SEQRES 35 A 465 SER ASP ALA ASN THR GLY ASP ARG GLY GLN THR ASN ASN SEQRES 36 A 465 ALA ALA SER ALA SER ALA SER ASN SER THR SEQRES 1 B 465 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 B 465 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET SEQRES 3 B 465 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 4 B 465 VAL PRO ARG GLY SER HIS MET SER GLY ARG PRO ARG THR SEQRES 5 B 465 THR SER PHE ALA GLU SER CYS LYS PRO VAL GLN GLN PRO SEQRES 6 B 465 SER ALA PHE GLY SER MET LYS VAL SER ARG ASP LYS ASP SEQRES 7 B 465 GLY SER LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN SEQRES 8 B 465 GLY PRO ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR SEQRES 9 B 465 LYS VAL ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN SEQRES 10 B 465 ALA LYS LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS SEQRES 11 B 465 LYS VAL LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU SEQRES 12 B 465 GLN ILE MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG SEQRES 13 B 465 LEU ARG TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP SEQRES 14 B 465 GLU VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU SEQRES 15 B 465 THR VAL TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS SEQRES 16 B 465 GLN THR LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR SEQRES 17 B 465 GLN LEU PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY SEQRES 18 B 465 ILE CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU SEQRES 19 B 465 ASP PRO ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SEQRES 20 B 465 SER ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER SEQRES 21 B 465 TYR ILE CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE SEQRES 22 B 465 PHE GLY ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SEQRES 23 B 465 SER ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN SEQRES 24 B 465 PRO ILE PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL SEQRES 25 B 465 GLU ILE ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN SEQRES 26 B 465 ILE ARG GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE SEQRES 27 B 465 PRO GLN ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG SEQRES 28 B 465 PRO ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG SEQRES 29 B 465 LEU LEU GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU SEQRES 30 B 465 GLU ALA CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP SEQRES 31 B 465 PRO ASN VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA SEQRES 32 B 465 LEU PHE ASN PHE THR THR GLN GLU LEU SER SER ASN PRO SEQRES 33 B 465 PRO LEU ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE SEQRES 34 B 465 GLN ALA ALA ALA SER THR PRO THR ASN ALA THR ALA ALA SEQRES 35 B 465 SER ASP ALA ASN THR GLY ASP ARG GLY GLN THR ASN ASN SEQRES 36 B 465 ALA ALA SER ALA SER ALA SER ASN SER THR HET DMS A1385 4 HET DMS A1386 4 HET 7YG A1387 31 HET DMS B1385 4 HET 7YG B1386 31 HETNAM DMS DIMETHYL SULFOXIDE HETNAM 7YG 3-AMINO-6-(4-{[2-(DIMETHYLAMINO) HETNAM 2 7YG ETHYL]SULFAMOYL}PHENYL)-N-PYRIDIN-3-YLPYRAZINE-2- HETNAM 3 7YG CARBOXAMIDE FORMUL 3 DMS 3(C2 H6 O S) FORMUL 5 7YG 2(C20 H23 N7 O3 S) FORMUL 8 HOH *512(H2 O) HELIX 1 1 ASN A 95 LYS A 103 1 9 HELIX 2 2 VAL A 139 ALA A 149 1 11 HELIX 3 3 PRO A 154 SER A 174 1 21 HELIX 4 4 LYS A 183 GLN A 185 5 3 HELIX 5 5 ALA A 224 PHE A 229 1 6 HELIX 6 6 SER A 236 GLY A 253 1 18 HELIX 7 7 SER A 261 GLY A 274 1 14 HELIX 8 8 THR A 277 ASN A 285 1 9 HELIX 9 9 PRO A 286 THR A 289 5 4 HELIX 10 10 PRO A 300 PHE A 305 1 6 HELIX 11 11 PRO A 310 LEU A 321 1 12 HELIX 12 12 THR A 324 ARG A 328 5 5 HELIX 13 13 THR A 330 ALA A 336 1 7 HELIX 14 14 HIS A 337 ASP A 345 5 9 HELIX 15 15 THR A 363 SER A 368 1 6 HELIX 16 16 ASN A 370 PRO A 372 5 3 HELIX 17 17 LEU A 373 ILE A 378 1 6 HELIX 18 18 ASN B 95 LYS B 103 1 9 HELIX 19 19 VAL B 139 ALA B 149 1 11 HELIX 20 20 PRO B 154 SER B 174 1 21 HELIX 21 21 LYS B 183 GLN B 185 5 3 HELIX 22 22 ALA B 224 PHE B 229 1 6 HELIX 23 23 SER B 236 GLY B 253 1 18 HELIX 24 24 SER B 261 GLY B 274 1 14 HELIX 25 25 THR B 277 ASN B 285 1 9 HELIX 26 26 PRO B 286 THR B 289 5 4 HELIX 27 27 PRO B 300 PHE B 305 1 6 HELIX 28 28 PRO B 310 LEU B 321 1 12 HELIX 29 29 THR B 324 ARG B 328 5 5 HELIX 30 30 THR B 330 ALA B 336 1 7 HELIX 31 31 HIS B 337 ASP B 345 5 9 HELIX 32 32 THR B 363 SER B 368 1 6 HELIX 33 33 ASN B 370 PRO B 372 5 3 HELIX 34 34 LEU B 373 ILE B 378 1 6 HELIX 35 35 PRO B 379 ILE B 384 1 6 SHEET 1 AA 7 THR A 38 PRO A 44 0 SHEET 2 AA 7 GLN A 52 ASN A 64 -1 O GLN A 52 N ALA A 42 SHEET 3 AA 7 VAL A 69 LEU A 75 -1 O VAL A 70 N ILE A 62 SHEET 4 AA 7 LEU A 81 GLN A 89 -1 O VAL A 82 N ALA A 73 SHEET 5 AA 7 VAL A 126 ASP A 133 -1 O VAL A 126 N GLN A 89 SHEET 6 AA 7 LEU A 112 SER A 118 -1 N ARG A 113 O VAL A 131 SHEET 7 AA 7 THR A 38 PRO A 44 -1 O THR A 43 N PHE A 115 SHEET 1 AB 3 GLU A 137 THR A 138 0 SHEET 2 AB 3 LEU A 187 LEU A 189 -1 O LEU A 189 N GLU A 137 SHEET 3 AB 3 LEU A 196 LEU A 198 -1 O LYS A 197 N LEU A 188 SHEET 1 AC 2 ILE A 177 CYS A 178 0 SHEET 2 AC 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178 SHEET 1 BA 7 THR B 38 PRO B 44 0 SHEET 2 BA 7 GLN B 52 ASN B 64 -1 O GLN B 52 N ALA B 42 SHEET 3 BA 7 VAL B 69 LEU B 75 -1 O VAL B 70 N ILE B 62 SHEET 4 BA 7 LEU B 81 LEU B 88 -1 O VAL B 82 N ALA B 73 SHEET 5 BA 7 TYR B 127 ASP B 133 -1 O LEU B 128 N VAL B 87 SHEET 6 BA 7 LEU B 112 SER B 118 -1 N ARG B 113 O VAL B 131 SHEET 7 BA 7 THR B 38 PRO B 44 -1 O THR B 43 N PHE B 115 SHEET 1 BB 3 GLU B 137 THR B 138 0 SHEET 2 BB 3 LEU B 187 LEU B 189 -1 O LEU B 189 N GLU B 137 SHEET 3 BB 3 LEU B 196 LEU B 198 -1 O LYS B 197 N LEU B 188 SHEET 1 BC 2 ILE B 177 CYS B 178 0 SHEET 2 BC 2 LYS B 205 GLN B 206 -1 O LYS B 205 N CYS B 178 SITE 1 AC1 7 ASP A 49 ARG A 50 PRO A 51 VAL A 142 SITE 2 AC1 7 TYR A 146 TYR A 161 PRO A 191 SITE 1 AC2 4 TYR A 56 TYR A 71 LYS A 86 ASN A 129 SITE 1 AC3 3 TYR B 56 LYS B 86 ASN B 129 SITE 1 AC4 11 PHE A 67 ALA A 83 LYS A 85 LEU A 132 SITE 2 AC4 11 ASP A 133 VAL A 135 PRO A 136 ARG A 141 SITE 3 AC4 11 LEU A 188 ASP A 200 HOH A2139 SITE 1 AC5 13 ILE B 62 PHE B 67 ALA B 83 LYS B 85 SITE 2 AC5 13 LEU B 132 ASP B 133 TYR B 134 VAL B 135 SITE 3 AC5 13 PRO B 136 ARG B 141 LEU B 188 ASP B 200 SITE 4 AC5 13 HOH B2130 CRYST1 83.080 85.810 177.530 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012037 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011654 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005633 0.00000